DK472887A - Imidazolylguanidinderivater, fremgangsmaade til fremstilling deraf og laegemidler, der indeholder disse forbindelser - Google Patents

Imidazolylguanidinderivater, fremgangsmaade til fremstilling deraf og laegemidler, der indeholder disse forbindelser

Info

Publication number
DK472887A
DK472887A DK472887A DK472887A DK472887A DK 472887 A DK472887 A DK 472887A DK 472887 A DK472887 A DK 472887A DK 472887 A DK472887 A DK 472887A DK 472887 A DK472887 A DK 472887A
Authority
DK
Denmark
Prior art keywords
ingrediates
imidazolylguanide
procedures
preparing
compounds
Prior art date
Application number
DK472887A
Other languages
English (en)
Other versions
DK472887D0 (da
DK165982C (da
DK165982B (da
Inventor
Armin Buschauer
Helmut Schickaneder
Peter Moersdorf
Walter Schunack
Gert Baumann
Kurt-Henning Ahrens
Original Assignee
Heumann Pharma Gmbh & Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Heumann Pharma Gmbh & Co filed Critical Heumann Pharma Gmbh & Co
Publication of DK472887D0 publication Critical patent/DK472887D0/da
Publication of DK472887A publication Critical patent/DK472887A/da
Publication of DK165982B publication Critical patent/DK165982B/da
Application granted granted Critical
Publication of DK165982C publication Critical patent/DK165982C/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/64—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with substituted hydrocarbon radicals attached to ring carbon atoms, e.g. histidine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing three or more hetero rings

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Pyridine Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
DK472887A 1986-09-15 1987-09-10 Imidazolylguanidinderivater og laegemidler, der indeholder disse forbindelser DK165982C (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE19863631334 DE3631334A1 (de) 1986-09-15 1986-09-15 Neue imidazolylguanidinderivate, verfahren zu ihrer herstellung und diese verbindungen enthaltende arzneimittel
DE3631334 1986-09-15

Publications (4)

Publication Number Publication Date
DK472887D0 DK472887D0 (da) 1987-09-10
DK472887A true DK472887A (da) 1988-03-16
DK165982B DK165982B (da) 1993-02-22
DK165982C DK165982C (da) 1993-07-26

Family

ID=6309606

Family Applications (1)

Application Number Title Priority Date Filing Date
DK472887A DK165982C (da) 1986-09-15 1987-09-10 Imidazolylguanidinderivater og laegemidler, der indeholder disse forbindelser

Country Status (17)

Country Link
US (1) US4912119A (da)
EP (1) EP0262448B1 (da)
JP (1) JPS6383072A (da)
KR (1) KR950010326B1 (da)
AT (1) ATE70533T1 (da)
AU (1) AU606882B2 (da)
CA (1) CA1249829A (da)
DE (2) DE3631334A1 (da)
DK (1) DK165982C (da)
ES (1) ES2040720T3 (da)
GR (1) GR3003388T3 (da)
HU (1) HU212302B (da)
IE (1) IE59278B1 (da)
IL (1) IL83804A (da)
NZ (1) NZ221611A (da)
PT (1) PT85697B (da)
ZA (1) ZA876163B (da)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3579000D1 (de) * 1985-04-02 1990-09-06 Heumann Pharma Gmbh & Co Imidazolylalkylguanidinderivate, verfahren zu ihrer herstellung und diese verbindungen enthaltende arzneimittel.
DE3726381A1 (de) * 1987-08-07 1989-02-16 Heumann Pharma Gmbh & Co Guanidincarbonsaeureester, verfahren zu ihrer herstellung und diese verbindungen enthaltende arzneimittel
DE3814057A1 (de) * 1988-04-26 1989-11-09 Heumann Pharma Gmbh & Co 6-oxo-pyridazinderivate, verfahren zu ihrer herstellung und diese verbindungen enthaltende arzneimittel
EP0448765B1 (de) * 1990-03-30 1994-08-17 HEUMANN PHARMA GMBH & CO Verwendung von Guanidinderivaten zur Herstellung eines Arzneimittels mit NPY-antagonistischer Wirkung
WO1992015567A1 (en) * 1991-02-27 1992-09-17 Seed Capital Investment (Sci) B.V. Imidazole-derivatives having agonistic or antagonistic activity on the histamine h3-receptor
NL9100365A (nl) * 1991-02-27 1992-09-16 Seed Capital Investments Imidazoolderivaten met agonistische of antagonistische activiteit op de histamine h3-receptor.
AU2031692A (en) * 1991-07-22 1993-01-28 Zyma S.A. Arylalkylamine derivatives
USRE37303E1 (en) * 1992-01-10 2001-07-31 Institut National Del La Sante Et De La Recherche Medicale Imidazole compounds and their therapeutic applications
FR2686084B1 (fr) * 1992-01-10 1995-12-22 Bioprojet Soc Civ Nouveaux derives de l'imidazole, leur preparation et leurs applications therapeutiques.
US6127343A (en) * 1996-05-14 2000-10-03 Novo Nordisk A/S Somatostatin agonists and antagonists
AU2764797A (en) * 1996-05-14 1997-12-05 Novo Nordisk A/S Somatostatin agonists and antagonists
JP2001502712A (ja) * 1996-10-31 2001-02-27 ノボ ノルディスク アクティーゼルスカブ 束縛されたソマトスタチン・アゴニスト及びアンタゴニスト
US5889016A (en) * 1997-06-26 1999-03-30 Bristol-Myers Squibb Company Dihydropyrimidone derivatives as NPY antagonists
CA2377698A1 (en) 1999-06-21 2000-12-28 Bristol-Myers Squibb Company Dihydropyrazine derivatives as npy antagonists
US6518287B2 (en) * 2000-09-20 2003-02-11 Schering Corporation Substituted imidazoles as dual histamine H1 and H3 agonists or antagonists
KR101892241B1 (ko) * 2015-11-06 2018-08-27 송재근 유분 분리 장치

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1431589A (en) * 1973-07-13 1976-04-07 Smith Kline French Lab Ureas, thioureas and guanidines n,n-disubstituted by heterocyclo- alkylene and/or heterocycloalkylenethioalkylene groups
IL49528A (en) * 1975-05-21 1980-11-30 Smith Kline French Lab Imidazolyl(or thiazolyl)methylthio(or butyl)guanidine or thiourea derivatives,their preparation and pharmaceutical compositions comprising them
DE2835695A1 (de) * 1977-08-29 1979-03-15 Yamanouchi Pharma Co Ltd Neue heterocyclische verbindungen, verfahren zu ihrer herstellung und arzneimittel, die diese enthalten
DK221081A (da) * 1980-05-31 1981-12-01 Smith Kline French Lab Fremgangsmaade til fremstilling af heterocyklylalkylanidiner mellemprodukter til anvendelse ved denne fremgangsmaade og en fremgangsmaade til fremstilling af disse mellemprodukter
JPH0660096B2 (ja) * 1983-11-04 1994-08-10 富山化学工業株式会社 アミン誘導体またはその塩を含有する抗潰瘍剤
DE3528214A1 (de) * 1985-08-06 1987-02-12 Heumann Ludwig & Co Gmbh Arylalkylguanidinderivate, verfahren zu ihrer herstellung und diese verbindungen enthaltende arzneimittel
DE3579000D1 (de) * 1985-04-02 1990-09-06 Heumann Pharma Gmbh & Co Imidazolylalkylguanidinderivate, verfahren zu ihrer herstellung und diese verbindungen enthaltende arzneimittel.
DE3726381A1 (de) * 1987-08-07 1989-02-16 Heumann Pharma Gmbh & Co Guanidincarbonsaeureester, verfahren zu ihrer herstellung und diese verbindungen enthaltende arzneimittel

Also Published As

Publication number Publication date
IL83804A (en) 1993-02-21
PT85697A (de) 1987-10-01
DE3631334A1 (de) 1988-03-17
KR950010326B1 (ko) 1995-09-14
DK472887D0 (da) 1987-09-10
ES2040720T3 (es) 1993-11-01
GR3003388T3 (en) 1993-02-17
CA1249829A (en) 1989-02-07
KR880003937A (ko) 1988-06-01
IE872463L (en) 1988-03-15
AU7767287A (en) 1988-03-17
HU212302B (en) 1996-05-28
NZ221611A (en) 1989-09-27
JPS6383072A (ja) 1988-04-13
EP0262448A1 (de) 1988-04-06
AU606882B2 (en) 1991-02-21
ATE70533T1 (de) 1992-01-15
DK165982C (da) 1993-07-26
HUT56352A (en) 1991-08-28
DK165982B (da) 1993-02-22
EP0262448B1 (de) 1991-12-18
IL83804A0 (en) 1988-02-29
PT85697B (pt) 1990-08-31
IE59278B1 (en) 1994-02-09
ZA876163B (en) 1988-02-23
DE3775319D1 (de) 1992-01-30
US4912119A (en) 1990-03-27

Similar Documents

Publication Publication Date Title
DK472887D0 (da) Imidazolylguanidinderivater, fremgangsmaade til fremstilling deraf og laegemidler, der indeholder disse forbindelser
FI872756A0 (fi) Med laserstraolning fungerande terapeutisk anordning.
DK233586D0 (da) 5-substituerede 1,3-thiazolidon-2,4-dion-forbindelser og farmaceutiske praeparater indeholdende disse
DE58909793D1 (de) Neue Benzopyran-Derivate, Verfahren zu ihrer Herstellung und ihre Verwendung sowie die Verbindungen enthaltenden Zubereitungen
NO166639C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive substituerte, basiske 2-aminotetraliner.
IT1207589B (it) Composizione di anticorpi monoclonali umani cross-protettivi.
DK204686D0 (da) Quinolylglycinamidderivater og fremgangsmaade til fremstilling deraf
ES549776A0 (es) Procedimiento para la preparacion de pirrolo-bencimidazoles
AR228011A1 (es) Procedimiento para la preparacion de derivados sustituidos de 2,5,5,8a-tetrametil-1,2,3,4,4a,5,6,7,8,8a-decahidronaftaleno-1-spiro-2'-(4',6',7'-sustituido-2',3'-dihidrobenzofurano)
ES2171663T3 (es) Nuevo procedimiento para la preparacion de nucleosidos.
AR216558A1 (es) Procedimiento de preparacion de 1,3-dihidro-3-(3',4',5'-trimetoxi-estiril)-6-metil-7-hidroxi-furo-(3,4,c)-piridina
DK0871612T3 (da) Kondenserede isoindoloner som proteinkinase C-inhibitorer
AR243181A1 (es) Procedimiento de sintesis para obtener nuevos (benzofuran-2-il) imidazoles que tienen actividad farmaceutica y sus sales.
IT8622467A0 (it) Procedimento per la sintesi di perfluoroalcadieni.
IT1158450B (it) Procedimento per la preparazione dell'eritro-alfa-2-piperidil-2,8-bis-(trifluorometil)-4-chinolinmetanolo
IT7820912A0 (it) Procedimento per la preparazione di derivati di cefalosporina, e composti cosi' preparati.
IT1225483B (it) Protesi ortopedica, particolarmente per la testa del femore.
ES512230A0 (es) "procedimiento de preparacion de derivados (7e,9z)-alcadienoles".
YU6087A (en) Process for obtaining 2-benzimidazole-ilalkylthiosulphinyl or sulphonyl derivatives
ES515068A0 (es) "procedimiento para la preparacion de n-(2-(((5-dimetilamino)-metil-2-furanil)-metil)-tio)-etil)-n'-(3,4-metilendioxibencil)-2-nitro-1,1-etendiamina".
DK688087A (da) Imidazolderivater, fremgangsmaade til fremstilling deraf og anvendelse deraf som antimycotiske midler
IT8621066A0 (it) Procedimento per la preparazione di composti eterociclici azotati.
IT8422744A1 (it) 4(3h)-pirimidoni 2,5-disostituiti aventi attivita! antagonista dei recettori della istamina h2
ES458139A1 (es) Procedimiento alternativo para la sintesis de n-ciano-n'me- til-n (2-((4-metil-5-imidazoli)-etil) guanidina.
IT8124457A0 (it) Procedimento per la preparazione del5-(1-idrossi-2-isopropilammino)buti l-8-idrossi-carbostirile (procaterolo).